Bahrain's National Health Regulatory Authority (NHRA) has approved Wegovy (semaglutide) pills, an oral GLP-1 treatment for obesity, in the kingdom. With this, Bahrain has become the second GCC country, after the UAE, and the fifth country worldwide to make the medicine available to its citizens.
As global spending on artificial intelligence (AI) is projected to exceed $2 trillion in 2026, senior government and industry leaders at a high-level panel discussion at the 27th edition of Intersec discussed how AI is quickly transitioning from 'deep tech' to everyday frontline operations in safety-critical environments.
